What is the best country for stem cell therapy for Scleroderma (Systemic Sclerosis)?
There is no evidence-based best-country ranking for systemic-sclerosis cell treatment. For autologous HSCT, prioritise an experienced accredited transplant centre with systemic-sclerosis cardiopulmonary expertise and multidisciplinary selection. For an MSC study, require prospective registration, regulator authorisation, independent ethics review, defined manufacturing controls, prespecified endpoints and a public results plan. Geography and price are secondary.
The cost picture for Scleroderma (Systemic Sclerosis)
Costs for specialist autologous HSCT and investigational MSC infusion are not comparable. HSCT involves mobilisation, conditioning chemotherapy, hospital care and prolonged monitoring; an MSC infusion is a different experimental product and procedure. Private quotations may exclude pre-treatment organ assessment, standard systemic-sclerosis care, travel and management of complications. Patients should obtain an itemised written quote and written confirmation of sponsor, insurer and patient responsibilities without treating price as evidence of benefit.
Am I a candidate? → · Scleroderma (Systemic Sclerosis): full overview → · Scleroderma (Systemic Sclerosis) cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Scleroderma (Systemic Sclerosis): cell-therapy evidence and registered trials
- How much does stem cell therapy for Scleroderma (Systemic Sclerosis) cost? (2026)
- Scleroderma (Systemic Sclerosis) stem cell therapy — your questions answered (2026)
- Scleroderma (Systemic Sclerosis): cell-therapy evidence by therapy class
- MSC vs HSCT for Scleroderma (Systemic Sclerosis): what the registries show